2019
DOI: 10.1371/journal.pone.0219970
|View full text |Cite
|
Sign up to set email alerts
|

Evaluation of macrophage activation syndrome in hospitalised patients with Kikuchi-Fujimoto disease based on the 2016 EULAR/ACR/PRINTO classification criteria

Abstract: Background To evaluate the impact of macrophage activation syndrome (MAS) on clinical features in patients with Kikuchi-Fujimoto disease (KFD) and to compare the features of MAS in KFD with those of adult-onset Still’s disease (AOSD) and systemic lupus erythematosus (SLE). Methods The medical records of febrile patients hospitalised with KFD between November 2005 and April 2017 were reviewed. Patients fulfilling the 2016 classification criteria for MAS were classified a… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1
1

Citation Types

1
19
0

Year Published

2020
2020
2024
2024

Publication Types

Select...
7
1

Relationship

0
8

Authors

Journals

citations
Cited by 12 publications
(20 citation statements)
references
References 37 publications
1
19
0
Order By: Relevance
“…In addition, the proportion of patients with KFD requiring glucocorticoid treatment was significantly higher in patients with MAS than in patients without MAS. 6 Despite previously stating that histopathological examination is the main stay in the diagnosis of KFD, there are other histological differential diagnosis such as lymphoid malignancies particularly non-Hodgkin's lymphomas, lymphadenopathy due to autoimmune disorders, primarily systemic lupus erythematosus (SLE) and infectious etiologies, such as Epstein-Barr virus, herpes simplex virus, Bartonella henselae and toxoplasmosis. 7 Hence experience and consultation with a senior pathologist is a must before providing a report of KFD.…”
Section: Discussionmentioning
confidence: 99%
“…In addition, the proportion of patients with KFD requiring glucocorticoid treatment was significantly higher in patients with MAS than in patients without MAS. 6 Despite previously stating that histopathological examination is the main stay in the diagnosis of KFD, there are other histological differential diagnosis such as lymphoid malignancies particularly non-Hodgkin's lymphomas, lymphadenopathy due to autoimmune disorders, primarily systemic lupus erythematosus (SLE) and infectious etiologies, such as Epstein-Barr virus, herpes simplex virus, Bartonella henselae and toxoplasmosis. 7 Hence experience and consultation with a senior pathologist is a must before providing a report of KFD.…”
Section: Discussionmentioning
confidence: 99%
“…The fever is periodic, irregular, and oscillates between 38.6°C and 40.5°C. 2,7,11 Chills, nausea and vomiting, rash, headache and joint pain, weight loss, night sweats, splenomegaly, and parotid gland enlargement are other symptoms often found in KFD. Cutaneous symptoms appear in up to 40% of KFD cases, most often affecting the face, trunk, and upper limbs.…”
Section: Symptomsmentioning
confidence: 99%
“…Both HLH and KFD are associated with abnormal activation of histiocytes. 2,4,11 The duration of KFD is varied. Symptoms usually resolve within 6 months, however in individual cases, they can persist for up to a year.…”
Section: Symptomsmentioning
confidence: 99%
See 1 more Smart Citation
“…SPTCL occasionally shows striking histologic overlap with lupus panniculitis [33] and some patients, including those with wild type HAVCR2, have underlying autoimmune diatheses including SLE [34]. Although there is excellent overall survival, the low SPTCL mortality rate is almost invariably attributable to concomitant hemophagocytic lymphohistiocytosis (HLH), which can occur albeit Dermatology Online Journal || Case Report with a much lower frequency in the settings of SLE, KFD, and SLE/KFD overlap [13,35,36]. Therefore, patients presenting with KFD or LEP should also be monitored for the development of HLH and efforts, including T-cell clonality testing, can be considered in select cases to help exclude SPTCL.…”
Section: A B C D E Fmentioning
confidence: 99%